0.97
+0.0522(+5.68%)
Currency In USD
| Previous Close | 0.92 |
| Open | 0.91 |
| Day High | 1 |
| Day Low | 0.91 |
| 52-Week High | 6.5 |
| 52-Week Low | 0.87 |
| Volume | 37,281 |
| Average Volume | 283,273 |
| Market Cap | 38.45M |
| PE | -0.73 |
| EPS | -1.33 |
| Moving Average 50 Days | 1.86 |
| Moving Average 200 Days | 2.77 |
| Change | 0.05 |
If you invested $1000 in TELA Bio, Inc. (TELA) since IPO date, it would be worth $72.81 as of April 25, 2025 at a share price of $0.972. Whereas If you bought $1000 worth of TELA Bio, Inc. (TELA) shares 5 years ago, it would be worth $89.75 as of April 25, 2025 at a share price of $0.972.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
TELA Bio to Announce First Quarter 2025 Financial Results
GlobeNewswire Inc.
Apr 17, 2025 8:05 PM GMT
MALVERN, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will r
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery
GlobeNewswire Inc.
Mar 31, 2025 11:00 AM GMT
The OviTex PRS portfolio now includes a larger option than any human acellular dermal matrix product on the marketMALVERN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused
TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire Inc.
Feb 27, 2025 9:05 PM GMT
MALVERN, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will re